| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,975 |
3,630 |
$140K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
1,687 |
1,627 |
$55K |
| 96112 |
|
646 |
611 |
$39K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
350 |
337 |
$18K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
544 |
530 |
$15K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
213 |
210 |
$14K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
211 |
205 |
$14K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
168 |
162 |
$11K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
184 |
180 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
148 |
142 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
151 |
110 |
$3K |
| 90473 |
|
106 |
104 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
168 |
158 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
18 |
17 |
$784.98 |
| 90651 |
|
13 |
12 |
$409.74 |
| 90686 |
|
431 |
423 |
$99.58 |
| 90461 |
|
441 |
415 |
$32.00 |
| 90680 |
|
13 |
13 |
$0.00 |
| 90672 |
|
122 |
119 |
$0.00 |
| 99072 |
|
687 |
637 |
$0.00 |
| 90670 |
|
41 |
41 |
$0.00 |
| 90649 |
|
12 |
12 |
$0.00 |
| 90633 |
|
13 |
12 |
$0.00 |